Buy Vinpocetine pills 5 mg 50 pcs
  • Buy Vinpocetine pills 5 mg 50 pcs

Vinpocetine

PFK Obnovlenie
603 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$20.25
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

A means of improving cerebral circulation and brain metabolism. Inhibits phosphodiesterase activity, which contributes to the accumulation of cAMP in tissues. It has a vasodilating effect mainly on the vessels of the brain, which is caused by direct myotropic antispasmodic action. Systemic blood pressure drops slightly. It improves blood flow and microcirculation in the brain tissues, reduces platelet aggregation, and contributes to the normalization of the rheological properties of blood. It improves the portability of hypoxia by brain cells, facilitating the transport of oxygen to tissues due to a decrease in the red blood cell affinity for it, enhancing the absorption and metabolism of glucose. Increases the content of catecholamines in brain tissue.

Indications

Acute and chronic cerebrovascular insufficiency. Dyscirculatory encephalopathy, accompanied by memory impairment, dizziness, headache. Posttraumatic encephalopathy. Vascular diseases of the retina and choroid. Hearing impairment of vascular or toxic origin, Meniere's disease, dizziness of labyrinth origin. Vegetative-vascular dystonia in climacteric syndrome.

Composition

1 tab .:
Vinpocetine 5 mg
Excipients: potato starch - 64.3 mg, lactose monohydrate (milk sugar) - 171.9 mg, colloidal silicon dioxide (aerosil) - 1.7 mg, talc - 4.7 mg, magnesium stearate - 2.4 mg.

Vinpocetine is marketed under different brands and generic names, and comes in different dosage forms:

Brand nameManufacturerCountryDosage form
Vinpocetine PFK Obnovlenie Russia pills
Vinpocetine Obolensky OP Russia pills
Vinpocetine Izvarino Pharma Russia pills
Vinpocetine-Akos Synthesis AKOMP Russia ampoules
Cavinton Comforte Gedeon Richter Hungary pills
Cavinton Gedeon Richter Hungary pills
Cavinton Gedeon Richter Hungary ampoules
Vinpocetin-Sar Biochemist Saransk Russia ampoules
Vinpocetine Gedeon Richter Hungary pills
Vinpocetine Canonpharma Russia pills
Cavinton Forte Gedeon Richter Hungary pills

No customer reviews for the moment.

Write your review

Write your review

Vinpocetine

Dosage and Administration

Maverex administered in / in (strictly), in the form of a 15-20 minute infusion. It is used both as a monotherapy and in combination with other antitumor agents. When choosing a dose and mode of administration in each individual case, refer to the special literature.

In monotherapy mode, the usual dose of Maverex is 25-30 mg / m2 of body surface once a week. The drug is diluted in 0.9% solution of sodium chloride or 5% dextrose solution to a concentration of 1.5-3.0 mg / ml. After the introduction of the drug, the vein should be washed by entering an additional 50-100 ml of 0.9% sodium chloride solution.

Adverse reactions

From the side of blood-forming organs: granulocytopenia, anemia; rarely - thrombocytopenia.

The smallest number of granulocytes is observed on days 7-10 from the start of therapy, recovery occurs in the next 7-14 days.

On the part of the nervous system: a decrease or loss of deep tendon reflexes, paresthesia, hyperesthesia, weakness in the legs, pain in the jaw, headache, intestinal paresis; rarely paralytic bowel obstruction.

On the part of the digestive system: nausea, vomiting, anorexia, constipation, diarrhea, dysphagia, mucositis, pancreatitis, increased bilirubin levels and increased activity of hepatic transaminases.

On the part of the respiratory system: difficulty breathing, shortness of breath, bronchospasm, interstitial pneumonia, acute respiratory distress syndrome.

Since the cardiovascular system: chest pain, increase or decrease in blood pressure, tachycardia; rarely - myocardial infarction, pulmonary edema.

Local reactions: pain or redness at the injection site; with extravasation - cellulite, phlebitis and, possibly, necrosis of the surrounding tissues.

Others: weakness, alopecia, myalgia, arthralgia, skin rashes, allergic reactions, flushes of heat to the face, increased creatinine levels, hyponatremia, hemorrhagic cystitis and syndrome of inappropriate antidiuretic hormone secretion.

  • Hypersensitivity to vinka alkaloids;
  • severe liver dysfunction;
  • baseline neutrophil count
  • radiation therapy of the hepatobiliary area;
  • pregnancy;
  • breastfeeding period.
  • Carefully:
  • respiratory failure;
  • oppression of bone marrow hematopoiesis (including after previous chemotherapy or radiation treatment);
  • constipation or a history of intestinal obstruction in history;
  • history of neuropathy.
  • Brand name: Vinelbin
  • Active ingredient: Vinorelbine
  • Dosage form: Concentrate for solution for infusion
  • Manufacturer: Fresenius Kabi
  • Country of Origin: Germany

Studies and clinical trials of Vinpocetine (Click to expand)

  1. Capillary electrophoresis separation of vinpocetine and related compounds: Prediction of electrophoretic mobilities in partly aqueous media
  2. Effects of vinpocetine in scopolamine-induced learning and memory impairments
  3. General neuropharmacology of vinpocetine: A putative cerebral activator
  4. Possible memory-enhancing properties of vinpocetine
  5. Correlation between cerebral circulation and intellectual impairment in patients with “aging brain,” and the effect of vinpocetine on cerebral circulation
  6. Restoration of microsieve filterability of human red cells after exposure to hyperosmolarity and lactacidosis: Effect of vinpocetine
  7. Computed tomography study of cerebral infarctions treated with vinpocetine
  8. Placebo-controlled, double-blind, crossover study to investigate the hypoxia-protective effect of vinpocetine by psychophysiological methodology in healthy volunteers
  9. On the possible role of central monoaminergic systems in the central nervous system actions of vinpocetine
  10. Effect of vinpocetine on monoamine receptor binding and synaptosomal uptake in the rat brain
  11. Vinpocetine facilitates noradrenaline release in rat brain cortex slices
  12. Calcium antagonist activity of vinpocetine and vincamine in several models of cerebral ischaemia
  13. Electrophysiologic effects of vinpocetine and vincamine on isolated rabbit papillary muscle in normal- and low-potassium medium
  14. Effect of vinpocetine on age-related differences in brain function of aged fischer rats
  15. Effect of vinpocetine on the sleep-wake cycle of rats
  16. Comparison of the effects of vinpocetine, vincamine, and nicergoline on the normal and hypoxia-damaged learning process in spontaneously hypertensive rats
  17. Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory
  18. Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome
  19. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine
  20. Multidisciplinary approach on characterizing a mechanochemically activated composite of vinpocetine and crospovidone
  21. Kinetics and mechanisms of vinpocetine degradation in aqueous solutions
  22. Quantitative determination of vinpocetine in human plasma by capillary gas chromatography—mass spectrometry
  23. Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo
  24. Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion

8 other products in the same category:

arrow_upward